Vor Biopharma annual net debt
2020
2021
2022
2023
2024
2025
Vor Biopharma Net Debt Growth & History (VOR)
Vor Biopharma's net debt was −$393.5M for fiscal 2025.
View full Vor Biopharma company overviewVor Biopharma annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$393.5M | −$343.4M | — |
| 2024 | 2024-12-31 | −$50.1M | −$54.4M | — |
| 2023 | 2023-12-31 | $4.3M | $23.1M | — |
| 2022 | 2022-12-31 | −$18.8M | $83.0M | — |
| 2021 | 2021-12-31 | −$101.8M | −$71.5M | — |
| 2020 | 2020-12-31 | −$30.2M | — | — |
Vor Biopharma quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$105.0M | $85.6M | — |
| Q1 2026 | 2026-03-31 | −$166.9M | −$147.7M | — |
| Q4 2025 | 2025-12-31 | −$393.5M | −$343.4M | — |
| Q3 2025 | 2025-09-30 | −$157.4M | −$137.5M | — |
| Q2 2025 | 2025-06-30 | −$190.6M | −$148.3M | — |
| Q1 2025 | 2025-03-31 | −$19.3M | −$9.0M | — |
| Q4 2024 | 2024-12-31 | −$50.1M | −$54.4M | — |
| Q3 2024 | 2024-09-30 | −$19.9M | −$11.5M | — |
| Q2 2024 | 2024-06-30 | −$42.3M | −$47.6M | — |
| Q1 2024 | 2024-03-31 | −$10.2M | −$6.2M | — |
| Q4 2023 | 2023-12-31 | $4.3M | $23.1M | — |
| Q3 2023 | 2023-09-30 | −$8.4M | $12.1M | — |
| Q2 2023 | 2023-06-30 | $5.3M | $26.4M | — |
| Q1 2023 | 2023-03-31 | −$4.0M | $57.1M | — |
| Q4 2022 | 2022-12-31 | −$18.8M | $83.0M | — |
| Q3 2022 | 2022-09-30 | −$20.5M | $104.9M | — |
| Q2 2022 | 2022-06-30 | −$21.1M | $130.5M | — |
| Q1 2022 | 2022-03-31 | −$61.1M | $183.2M | — |
| Q4 2021 | 2021-12-31 | −$101.8M | −$71.5M | — |
| Q3 2021 | 2021-09-30 | −$125.4M | — | — |
| Q2 2021 | 2021-06-30 | −$151.6M | — | — |
| Q1 2021 | 2021-03-31 | −$244.3M | — | — |
| Q4 2020 | 2020-12-31 | −$30.2M | — | — |
Vor Biopharma net debt trends
Over the last five fiscal years, Vor Biopharma's net debt decreased from −$30.2M to −$393.5M, a change of −$363.2M. The latest reported quarter, Q2 2026, shows −$105.0M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vor Biopharma source filings ↗